PG
ALNY icon

PEAK6 Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

PEAK6 Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-51,400
Closed -$6.12M – 4251
2018
Q1 		$6.12M Buy
51,400
+20,900
+69% +$2.69M 0.03% 704
2017
Q4 		$3.88M Sell
30,500
-25,900
-46% -$3.25M 0.02% 958
2017
Q3 		$6.63M Buy
+56,400
New +$4.81M 0.03% 601
2017
Q2 		– Sell
-13,800
Closed -$707K – 4482
2017
Q1 		$707K Sell
13,800
-2,800
-17% -$129K 0.01% 1964
2016
Q4 		$622K Buy
16,600
+10,000
+152% +$419K ﹤0.01% 2308
2016
Q3 		$447K Sell
6,600
-4,800
-42% -$339K ﹤0.01% 2430
2016
Q2 		$633K Buy
11,400
+8,200
+256% +$517K ﹤0.01% 2177
2016
Q1 		$201K Buy
+3,200
New +$213K ﹤0.01% 3121
2015
Q4 		– Sell
-400
Closed -$32K – 4673
2015
Q3 		$32K Sell
400
-8,300
-95% -$922K ﹤0.01% 4788
2015
Q2 		$1.04M Sell
8,700
-40,000
-82% -$4.78M 0.01% 2046
2015
Q1 		$5.08M Buy
48,700
+29,300
+151% +$2.97M 0.04% 673
2014
Q4 		$1.88M Buy
19,400
+2,800
+17% +$259K 0.01% 1379
2014
Q3 		$1.3M Buy
16,600
+10,000
+152% +$645K 0.01% 1600
2014
Q2 		$417K Sell
6,600
-8,700
-57% -$517K ﹤0.01% 2483
2014
Q1 		$1.03M Buy
+15,300
New +$1.18M 0.01% 1845
2013
Q4 		– Sell
-106,300
Closed -$6.8M – 4840
2013
Q3 		$6.8M Buy
106,300
+59,400
+127% +$2.96M 0.05% 550
2013
Q2 		$1.45M Buy
+46,900
New +$1.25M 0.01% 1823

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

PEAK6 Group's ALNY Position: Q1 2018 in Review

PEAK6 Group sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2018, closing a stake of 25,752 shares — an estimated $3.32M sold.

PEAK6 Group first reported a position in ALNY in Q3 2014 and held it in 13 quarters. The position peaked at $4.13M in Q2 2015. 293 funds tracked by Wall St. Rank hold ALNY as of Q1 2018.

  • PEAK6 Group reported no remaining Alnylam Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 25,752 Alnylam Pharmaceuticals shares in Q1 2018, an estimated $3.32M.
  • PEAK6 Group first reported a position in Alnylam Pharmaceuticals in Q3 2014 and held it in 13 quarters.
  • PEAK6 Group's Alnylam Pharmaceuticals position peaked at $4.13M in Q2 2015.
  • 293 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.